Authors
Loading...
Novel framework VUS.Life classifies genetic variant pathogenicity in BRCA1 and BRCA2, suggesting high accuracy.
Wu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: